Objective-Previous intervention research conducted in Appalachian Kentucky resulted in extremely low uptake and adherence to the human papillomavirus (HPV) vaccine among women ages 18 -26, despite provision of free vaccine. Because of these findings, the purpose of this qualitative, follow-up study was to elicit health care providers' perspectives on barriers and facilitators to HPV vaccination and suggested strategies for improving vaccination rates.Design and Sample-Researchers conducted semi-structured qualitative interviews with a purposive sample of eight health care providers (seven nursing professionals, one physician) at the health clinic where the original HPV vaccination intervention took place. Interviews were audiorecorded and transcribed and authors used a constant-comparative method to analyze the data.Results-Significant themes emerged from the interviews, centering around two primary issues: vaccine uptake and vaccine adherence. Related to uptake, health care providers identified perceived patient barriers and inadequate HPV vaccine education. They also identified the vaccine schedule and clinic-centered communication deficiencies as adherence-related barriers.
Conclusion-TheseAppalachian Kentucky health care providers provided important insights into barriers and facilitators to HPV vaccine uptake and adherence that need to be readily addressed in this community. As informed by these providers, several suggestions for improving HPV vaccination, such as more targeted education efforts and patient-centered reminder systems, may be applicable to other nursing professionals working in rural and medically underserved communities.
HHS Public Access
Author Manuscript Author ManuscriptAuthor Manuscript
Author ManuscriptUptake and adherence to the three-dose human papillomavirus (HPV) vaccine remains low, which is particularly concerning for communities that shoulder an excessive burden of cervical cancer and have limited access to health care, such as Appalachian Kentucky. A previous intervention study conducted in this geographic region revealed low HPV vaccination rates among young women ages 18-26, despite waiving the cost of the vaccine series. The current study serves as a qualitative follow-up to this previous intervention research, seeking to understand health care providers' perspectives on actual barriers and facilitators to HPV vaccination and garnering strategies for improving vaccination rates in this region.